Brentwood, Tenn.-based Surgery Partners reported a record-breaking $3.1 billion in annual revenue, while Bain Capital’s bid ...

Surgery Partners has a fifty-two week low of $19.50 and a fifty-two week high of $33.97. The business’s 50 day moving average price is $23.93 and its 200-day moving average price is $25.74.

Healthcare company Surgery Partners (NASDAQ:SGRY) in Q4 CY2024, with sales up 17.5% year on year to $864.4 million. The company expects the full year’s revenue to be around $3.38 billion ...

In a report released yesterday, Ben Hendrix from RBC Capital maintained a Buy rating on Surgery Partners (SGRY – Research Report), with a price ...

Learn more about whether RadNet, Inc. or Surgery Partners, Inc. is a better investment based on AAII's A+ Investor grades, ...

TD Cowen lowered the firm’s price target on Surgery Partners (SGRY) to $28 from $32 and keeps a Buy rating on the shares. The firm updated its model following Q4 results which were generally ...

Healthcare company Surgery Partners (NASDAQ:SGRY) will be announcing earnings results tomorrow before market open. Here’s what you need to know. Surgery Partners met analysts’ revenue ...

Here are 10 trends within the ASC industry shaping the way that leaders and physicians approach ASC finances in 2025: 1.

Healthcare company Surgery Partners (NASDAQ:SGRY) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 17.5% year on year to $864.4 million. The company expects the full year’s ...

Learn more about whether Patterson Companies, Inc. or Surgery Partners, Inc. is a better investment based on AAII's A+ ...